Hamid Ghandehari, distinguished scientist and expert in drug delivery innovation, will visit the NDSU Department of Pharmaceutical Sciences to share information about engineering nanoconstructs for targeted drug and gene delivery. He will visit with faculty and graduate students and deliver a presentation on Tuesday, Oct. 6, at 11:30 a.m. in Sudro Hall, room 20A/20B. The seminar is free and open to the public.

Ghandehari joined the Departments of Pharmaceutics and Pharmaceutical Chemistry and Bioengineering at the University of Utah in November 2007. He previously worked at the University of Maryland, Baltimore, as professor of pharmaceutical sciences, founding director of the Center for Nanomedicine and Cellular Delivery and member of Greenebaum Cancer Center.

His research, funded by the National Institutes of Health, National Science Foundation and other agencies, focuses on the design of new polymers for gene therapy of head and neck cancer, targeted delivery of antiangiogenic inhibitors, oral delivery of chemotherapeutics by polymeric carriers, assessing the biocompatibility and cellular trafficking of organic and inorganic nanoconstructs, and design and development of stimuli-sensitive hybrid nanoparticles for controlled chemical delivery.

Ghandehari is executive editor of Advanced Drug Delivery Reviews and serves on editorial boards of the Journal of Controlled Release, Pharmaceutical Research, Nanomedicine: Nanotechnology, Biology and Medicine and the Journal of Bioactive and Compatible Polymers.

For further information, contact Jagdish Singh at 1-7943.